aiGENE is a US-based company developing a rapid, inexpensive, universal, pan-cancer screening test using DNA methylation technology licenced from The University of Queensland, Australia in 2020. The company’s approach uses an electrode based meter that generates a digital readout based on the amount of cancer DNA in a person’s blood. The “aiElectrode” is selectively sensitive […]

View post to subscribe to site newsletter.

Founded in 2020, Asalyxa Bio is a spinout from the University of Michigan, focused on the rapid development of a new neutrophil-targeting drug platform. Neutrophils are immune cells that are involved in the systemic response to infection and injury. Asalyxa’s proprietary platform allows for the direct delivery of microparticles into neutrophils, making the platform suitable […]

View post to subscribe to site newsletter.

Macomics is a UK-based start-up focused on the development of novel, first-in-class immunotherapies designed to modulate macrophages, increasing the body’s immune defence against tumours. Macomics’ approach is based on leading academic research around macrophage biology, particularly in cancer, from the laboratory of Professor Jeffrey Pollard, Director of the MRC Centre for Reproductive Health at the […]

View post to subscribe to site newsletter.